REG - One Health Group PLC - Full Planning Application Surgical Hub

One HealthAnnouncement

31/03/2025 07:15

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250331:nRSe7666Ca&default-theme=true

RNS Number : 7666C  One Health Group PLC  31 March 2025

31 March 2025

One Health Group plc

("One Health" or the "Company")

Full Planning Application Submitted for One Health Surgical Hub

One Health Group plc (AIM: OHGR), a provider of NHS-funded medical procedures,
is pleased to announce that contracts have been exchanged to purchase land in
the North of England as previously announced, and a full planning application
has now been submitted for the construction of the first One Health Surgical
Hub. Based on positive feedback received from a pre-planning application the
Company anticipates approval being granted. Subject to planning approval,
construction work is expected to commence in H1 2025/26.

 

For more information, please contact:

 

 One Health Group plc                           via Square1 Consulting

 Derek Bickerstaff, Chairman

 Adam Binns, CEO

 Panmure Liberum, Nominated Adviser and Broker  Tel: +44 (0) 20 3100 2000

 Emma Earl, Will Goode, Mark Rogers

 Rupert Dearden

 Square1 Consulting                             Tel: +44 207 929 5599

 David Bick                                     +44 7831 381201

Further information on the Company can be found on its website at
www.onehealth.co.uk (http://www.onehealth.co.uk) .

 

 

About One Health Group plc

One Health engages over 70 NHS Consultants (excluding anaesthetists) who
sub-specialise in the various surgeries offered by the Company, through a
growing network of community-based outreach clinics and surgical operating
locations. One Health continues to deliver strong growth and in the year to
March 2024 provided much needed care to 13,266 new patients, through almost
34,000 consultations and over 6,000 surgical procedures. One Health deploys
surgeons and anaesthetists that are mostly employed by the NHS, on a
subcontracted basis. It currently works with over 100 professionals across 9
independent hospitals and 37 outreach clinics. Within these community-based
outreach clinics all consultations and post operative physiotherapy is
delivered where required, reducing patient inconvenience and excess travel.

One Health's activities are focused on areas where NHS patient needs are
under-supplied by the local NHS service, population density is relatively high
and the level of private medical insurance or the ability to self-fund is
relatively low. One Health has also sought to expand geographically from its
Head Office in Sheffield into neighbouring counties which meet these criteria.
Currently, the Company's activities are focused in Yorkshire, Lincolnshire,
Derbyshire, Nottinghamshire and Leicestershire. Revenue of over £23 million
in the year to 31 March 2024 was derived from over 60 NHS commissioning bodies
in addition to contracts with local NHS Hospital Trusts to transfer their
internal waiting list patients to One Health for quicker treatment.

One Health's business model has focused to date on four main areas:
orthopaedics, spine, general surgery and gynaecology. The split of inpatient
procedures in the year to 31 March 2024 was as follows: orthopaedics 46% spine
22% general surgery 22% gynaecology 10%.

Spine and orthopaedics are particularly attractive areas for One Health as the
Directors believe that they benefit from powerful growth drivers in terms of
an ageing demographic, physical inactivity and an increasing proportion of the
population being categorised as obese. Within orthopaedics, the most common
surgeries performed by One Health are knee and hip replacements.

*(https://www.onehealth.co.uk/investors
(https://www.onehealth.co.uk/investors) )

 

The Directors of One Health Group plc accept responsibility for the contents
of this announcement

 

ends

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCPPURPWUPAGQR